Chairman of the Board and Chief Executive Officer | Read more
Chief Executive Officer, Global Distribution and Technology | Read more
Co-Chief Executive Officer, Global Oral Reconstruction Group | Read more
Senior Advisor | Read more
Executive Vice President and Chief Operating Officer | Read more
Senior Vice President, Chief Corporate Affairs Officer | Read more
Executive Vice President, Chief Strategic Officer, Member of the Board of Directors | Read more
Senior Vice President, Global Supply Chain | Read more
Senior Vice President and General Counsel | Read more
Senior Vice President and Chief Technology Officer | Read more
Chief Executive Officer, Henry Schein Products Group | Read more
Senior Vice President, Chief Human Resources Officer | Read more
Senior Vice President and Chief Legal Officer | Read more
Senior Vice President, Chief Financial Officer | Read more
Chairman of the Board and Chief Executive Officer
Since 1989, Stanley M. Bergman has been Chairman of the Board and CEO of Henry Schein, Inc., a Fortune 500® company and the world's largest provider of health care products and services to office-based dental and medical practitioners, with approximately 25,000 Team Schein Members worldwide and operations or affiliates in 33 countries and territories. Henry Schein is a member of the S&P 500® index. In 2024 , the Company's sales reached $12.7 billion . Henry Schein has earned a top score on the Human Rights Campaign Foundation's Corporate Equality Index since 2015.
Mr. Bergman serves as a board member or advisor for numerous institutions including: as Chair, Dean's Strategic Advisory Council, New York University College of Dentistry; Chairman of the Board, the University of the Witwatersrand Fund; Governor and Former Co-Chair, Global Health & Healthcare Governors Community, World Economic Forum; and Director Emeritus, Board of Overseers, Penn Dental Medicine. Mr. Bergman is an honorary member of the American Dental Association and the Alpha Omega International Dental Society. Mr. Bergman is a recipient of the Ellis Island Medal of Honor; the CR Magazine Corporate Responsibility Lifetime Achievement Award; the 2017 CEO of the Year award by Chief Executive Magazine; the National Association of Wholesaler-Distributors (NAW) Dirk Van Dongen Lifetime Achievement Award; Honorary Doctorates from The University of the Witwatersrand, Western University of Health Sciences, Hofstra University, A.T. Still University's Arizona School of Dentistry and Oral Health, Case Western Reserve University, Farmingdale State College (SUNY), and The Hebrew University of Jerusalem; and Honorary Fellowship from King's College London - Dental Institute and the International College of Dentists. Stan and Dr. Marion Bergman and their family are active supporters of organizations fostering the arts, higher education, cultural diversity and grassroots health care and sustainable entrepreneurial economic development initiatives in the United States, Africa and other developing regions of the world.
Mr. Bergman is a graduate of The University of the Witwatersrand in South Africa, and is a South African Chartered Accountant (CA SA) and a NYS Certified Public Accountant (CPA). To read Mr. Bergman's articles on LinkedIn, please click here.
View more »
2024
2023
2022
2021
2020
Older
Chief Executive Officer, Global Distribution and Technology
ANDREA ALBERTINI has been with the Company since 2013, and in his current position as Chief Executive Officer, Global Distribution and Technology within the Global Distribution Group, overseeing a diverse portfolio of businesses that includes Dental and Medical Distribution, Lab & Prosthetics, Technology and Value-Added Services, since January 2025. He is also a member of our Executive Management Committee and has executive responsibility for our partnership with Henry Schein One, our joint venture with Internet Brands. Prior to his current position, Mr. Albertini held several key leadership positions at the Company, steadily increasing his scope of responsibility. He served as Chief Executive Officer, International Distribution Group from February 2023 to January 2025 and as President, International Distribution Group from 2021 to February 2023. Previously he was President of our EMEA Dental Distribution Group from 2019 to 2021 and Vice President of International Dental Equipment from 2013 to 2019. Before joining the Company, Mr. Albertini held leadership positions at Cefla and Castellini, both leading global manufacturers of dental and medical equipment and instruments. Through his more than 20 years of experience in the health care industry, Mr. Albertini has developed deep expertise in managing a diverse portfolio of businesses and fostering strong, trusted relationships with suppliers, customers, and internal teams. Mr. Albertini holds a Master of Engineering from Bologna University, Italy, and a Master of Business Administration from Profingest Business School, Bologna, Italy.
Senior Advisor
JAMES P. BRESLAWSKI has been with the Company since 1980, in his current position as Senior Advisor since April 1, 2025. He is also a member of our Executive Management Committee. Mr. Breslawski held the position of President from 2005 to April 1, 2025, Vice Chairman from 2018 to May 2024, and as a director from 1992 to May 2024. He held the position of Chief Executive Officer of our Global Dental Group from 2005 to 2018. He also held the position of Executive Vice President and President of U.S. Dental from 1990 to 2005, with primary responsibility for the North American Dental Group. Between 1980 and 1990, Mr. Breslawski held various positions with the Company, including Chief Financial Officer, Vice President of Finance and Administration and Corporate Controller. Mr. Breslawski partners with our senior leadership team to address corporate and strategic priorities. Mr. Breslawski has served as Chairman of the board of directors of the American Dental Trade Association, Chairman of the board of directors of the Dental Trade Alliance Foundation and President of the Dental Dealers of America. He is also a former member of the Leadership Council, School of Dental Medicine at Harvard University, a former board member of the Dental Life Network (formerly the National Foundation of Dentistry for the Handicapped), a former member of the Board of Governors for St. John’s University and a former trustee of Long Island University. Mr. Breslawski is a member of the board of directors of the Henry Schein Cares Foundation, Inc. Mr. Breslawski is also a Certified Public Accountant.
Senior Vice President and Chief Global Customer Experience Officer
Ms. Clark joined Henry Schein in 2007 and is Senior Vice President and Chief Global Customer Experience Officer. She is also a Member of the Company's Executive Management Committee.
A seasoned veteran in health care technology, Ms. Clark has nearly 25 years industry experience and has served in a variety of leadership roles at Henry Schein. Previously, Ms. Clark served as Vice President, Technology Enablement, North America Distribution Group for Henry Schein, Inc., which includes Henry Schein's Dental and Medical distribution businesses. In 2017, she was appointed co-lead of Henry Schein's Global Digital Commerce team to champion and advance digital commerce and digital marketing initiatives, and in 2018, appointed to the Transformation Management Office, which is a strategic initiative designed to satisfy the evolving needs of customers and fuel future growth for both the customer and the company to create an engaging and frictionless online customer experience.
Prior to joining Henry Schein, Ms. Clark led the program management, customer relations, and marketing functions for eSurg, an online distributor of pharmaceutical, surgical, office, and medical supplies. In addition to her business contributions, Ms. Clark is a founding member of Henry Schein's Diversity & Inclusion Council, and is an Executive Sponsor of Henry Schein's Women's Leadership Network, as well as elevASIAN, its newly established Pan Asian employee resource group.
Ms. Clark earned her Bachelor of Arts degree in Social Sciences from University of Washington.
BRAD CONNETT has been with the Company since 1997, and in his current position as Senior Advisor since April 1, 2025. He is also a member of our Executive Management Committee. Prior to holding his current position, Mr. Connett held positions of increasing responsibility within the Company, including Chief Executive Officer, North America Distribution Group from 2021 to April 1, 2025, and President, U.S. Medical Group from 2019 through September 2021. Throughout his career, he has received numerous industry honors, including the John F. Sasen Leadership Award from the Health Industry Distributors Association (HIDA) in recognition of his service to the industry, and induction into the Medical Distribution Hall of Fame by Repertoire Magazine.
Executive Vice President and Chief Operating Officer
MICHAEL S. ETTINGER has been with the Company since 1994, and in his current position as Executive Vice President and Chief Operating Officer of the Company since 2022. He is also a member of our Executive Management Committee. As Executive Vice President and Chief Operating Officer, Mr. Ettinger oversees the Office of the CEO (including Henry Schein Cares, the Company’s global corporate social responsibility program), as well as the Company’s corporate affairs, corporate communications, legal, compliance and regulatory, global human resources, global security, global supply chain and information technology functions. Mr. Ettinger is also a member of the board of directors of the Henry Schein Cares Foundation, Inc. Prior to his current position, Mr. Ettinger served as Senior Vice President, Corporate & Legal Affairs and Chief of Staff, Secretary from 2015 to 2022; Senior Vice President, Corporate & Legal Affairs and Secretary from 2013 to 2015; Corporate Senior Vice President, General Counsel & Secretary from 2006 to 2013; Vice President, General Counsel and Secretary from 2000 to 2006; Vice President and Associate General Counsel from 1998 to 2000 and Associate General Counsel from 1994 to 1998. Before joining the Company, Mr. Ettinger served as a senior associate with Bower & Gardner and as a member of the Tax Department at Arthur Andersen. Mr. Ettinger earned a bachelor's degree in economics at Binghamton University, State University of New York, and a JD/MBA from the University at Buffalo School of Law, State University of New York.
Executive Vice President, Chief Strategic Officer, Member of the Board of Directors
MARK E. MLOTEK has been with the Company since 1994, in his current position as Executive Vice President and Chief Strategic Officer since 2012 and as a director since 1995. Mr. Mlotek’s directorship will end on May 22, 2025. Mr. Mlotek is a member of our Executive Management Committee. Mr. Mlotek was Senior Vice President and subsequently Executive Vice President of the Corporate Business Development Group between 2000 and 2012. Prior to that, Mr. Mlotek was Vice President, General Counsel and Secretary from 1994 to 1999. Prior to joining the Company, from 1989 to 1994, Mr. Mlotek was a partner in the law firm of Proskauer Rose LLP, the Company’s principal law firm and one of the largest firms in the nation, specializing in mergers and acquisitions, corporate reorganizations and tax law. As the Company continues to grow through strategic acquisitions, the Company values Mr. Mlotek’s extensive legal, merger and acquisition and business development experience as well as his drive for innovation and his entrepreneurial spirit. Mr. Mlotek also manages the Company’s global strategic planning function. Mr. Mlotek graduated from the Columbia University School of Law with high honors in 1980. He received an LL.M. in Taxation from New York University School of Law in 1985, also graduating with honors. Mr. Mlotek graduated summa cum laude with a B.S. degree in accounting from the Herbert Lehman University of City College of New York in 1977. Mr. Mlotek has been active in various charitable organizations, many of which help the perpetuation of the Yiddish language and culture. From 1996-2000, he served on the Conference of Presidents of Major American Jewish Organizations. Mr. Mlotek is a member of the New York State Bar Association.
Senior Vice President, Chief Corporate Affairs Officer
DAVID KOCHMAN has been with the Company since 2015, and in his current position as Senior Vice President, Chief Corporate Affairs Officer since January 2025, with responsibility for the Company’s global Communications, Professional Relations and Strategic Partnerships, Government Relations, Public Policy, Sustainability and CSR, Team Engagement, Customer and Employee Experience, and Creative Services functions, as well as the management and administration of projects and initiatives originating from the Office of the CEO. He is also a member of our Executive Management Committee. Since joining Henry Schein, Mr. Kochman has held key positions of increasing responsibility, most recently serving as Vice President, Chief Corporate Affairs Officer, from May 2022 to January 2025, and Vice President, Corporate Affairs & Deputy Chief of Staff, Office of the CEO from July 2015 to May 2022. Previously, Mr. Kochman acted as the General Counsel and Corporate Development Officer for a privately-held company in the regulated consumer products industry, and was a Partner in the New York office of the international law firm Reed Smith LLP. Before law school, Mr. Kochman worked in Jerusalem for the Deputy Speaker of the Israeli Knesset. Mr. Kochman is actively involved with charitable organizations focused on health care and criminal justice, and currently serves on the Board of Directors of both MedShare International (Atlanta) and The Fortune Society (NYC), as well as the NYU College of Dentistry Dean’s Strategic Advisory Council, University of Michigan School of Dentistry Dean’s Advisory Board, Penn Dental Medicine Board of Advisors, and Temple University School of Dentistry Board of Visitors. Mr. Kochman also has undertaken pro bono representation of Alabama death row inmates in post-conviction proceedings, and has received numerous awards recognizing his dedication to public service. Mr. Kochman received his Bachelor of Arts in Philosophy from Emory University and Juris Doctorate from the Benjamin N. Cardozo School of Law.
Senior Vice President, Global Supply Chain
JAMES MULLINS has been with the Company since 1988, and in his current position as Senior Vice President, Global Supply Chain since 2018. He is also a member of our Executive Management Committee. Mr. Mullins is responsible for leading global supply chain, the U.S. customer service function, facilities management, acquisitions and integration activity for Global Services and partnering with the Company’s specialty manufacturing business leaders to share best practices across the organization. Prior to holding his current position, Mr. Mullins held a number of key positions of increasing responsibility within the Company, including Global Chief Customer Service Officer. Mr. Mullins earned his Bachelor of Science in Business Administration and Management from St. John's University.
Senior Vice President and General Counsel
KELLY MURPHY has been with the Company since 2011, and in her current position as Senior Vice President and General Counsel since 2021. She is also a member of our Executive Management Committee. Prior to holding her current position, Ms. Murphy held several key positions of increasing responsibility within the Company’s legal function, most recently serving as Vice President and Deputy General Counsel from 2020 to 2021. As General Counsel, she is responsible for the Company’s legal activities related to mergers and acquisitions globally, corporate governance, litigation and other general corporate legal matters. Through her prior positions within the Company, Ms. Murphy attained significant legal experience and expertise, including with respect to mergers and acquisitions, partnerships, securities, litigation and regulatory matters. Ms. Murphy began her legal career as a legal associate at the global law firm of Clifford Chance, LLP, where she represented companies and financial institutions on a variety of domestic and international corporate matters. Ms. Murphy earned her Bachelor of Science in Communications from Boston University and a Juris Doctorate from Fordham University School of Law.
Senior Vice President and Chief Technology Officer
CHRISTOPHER PENDERGAST has been with the Company since 2018 as Senior Vice President and Chief Technology Officer. He is also a member of our Executive Management Committee. Mr. Pendergast brings more than 30 years of experience leading large-scale global IT organizations for companies experiencing growth through acquisition, global expansion and implementing new business models. His expertise includes leading organizations through transformational change, connecting IT to the needs of the business, converting digital complexity into strategy and aligning IT costs. Prior to joining the Company, Mr. Pendergast held global leadership roles, including Chief Technology Officer and Chief Information Officer, at VSP Global, which provides access to eye care and eyewear. During his 10 year tenure at VSP Global, he drove strategy and continuous transformation, optimization and modernization initiatives. Prior to VSP Global, he served in roles of increasing responsibility at Natural Organics, Inc., IdeaSphere Inc./Twinlab Corporation, Rohm and Hass and IBM Corporation. Mr. Pendergast earned his Bachelor of Business Administration in Business Computer Information Systems, and his Master of Business Administration from Hofstra University.
Senior Vice President, Chief Human Resources Officer
CHRISTINE SHEEHY has been with the Company since 2019, and in her current position as Senior Vice President, Chief Human Resources Officer since November 2024. She is also a member of our Executive Management Committee. Ms. Sheehy is responsible for managing the Company's Global Human Resources function, including Global Talent and Development, Total Rewards (Compensation and Benefits), HR M&A, Employee Relations, HR Operations & Strategy, HR Information Systems and the HR Business Partners. In addition to her day-to-day responsibilities managing the Global Human Resources function, Ms. Sheehy leads and participates in numerous strategic projects, such as business integrations, organizational design implementations, deal due diligence, TSM communications, Wellness, Engagement and other global best practices and strategies. Her overarching priority is to align the Company's talent strategies with business needs in the service of growth. Since joining Henry Schein, Ms. Sheehy has held several key positions with increasing responsibility, including serving as Vice President of the Human Resources Business Partner function for the Company’s North America Distribution Group (NADG), HSG, several Global Oral Reconstruction Group (GORG) businesses, and our Corporate Functions. Prior to joining the Company, Ms. Sheehy served as Managing Director, Regional Head of Human Resources, for Europe, USA, Canada & Latin America, for Standard Chartered Bank. Earlier in her career, she worked as a Systems Analyst and then Manager of Technology for the North America subsidiary of Brazil's Banco Real. Ms. Sheehy is a certified StrengthsFinder Coach and received her B.S. in Applied Mathematics from the State University of New York at Albany.
Senior Vice President and Chief Legal Officer
WALTER SIEGEL has been with the Company since 2013 and in his current position as Senior Vice President and Chief Legal Officer since 2021. He is also a member of our Executive Management Committee. Mr. Siegel is responsible for the Company’s worldwide legal, compliance and regulatory functions and activities. He previously served as Senior Vice President and General Counsel from 2013 to 2021, where he advised the Company on a broad range of legal matters affecting various business units. In this role, he managed the Company’s mergers and acquisitions activities, litigation portfolio, intellectual property portfolio and SEC reporting. Mr. Siegel manages input from outside counsel on corporate and litigation matters, and oversees and participates in drafting a broad range of commercial documents and contracts between the Company’s business units (and affiliates) and third parties. Mr. Siegel brings to the Company a diverse and wide background of legal expertise, including mergers and acquisitions, partnerships, securities, litigation and regulatory matters. From 2005 to 2012, Mr. Siegel held positions of increasing responsibility, including Senior Vice President, General Counsel and Secretary, for Standard Microsystems Corporation, a publicly traded global semiconductor company. Mr. Siegel is a Yale Law School graduate.
Senior Vice President, Chief Financial Officer
RONALD N. SOUTH has been with the Company since 2008 and in his current position as Senior Vice President and Chief Financial Officer (and principal financial officer and principal accounting officer) since April 2022. He is also a member of our Executive Management Committee and a member of the board of directors of the Henry Schein Cares Foundation, Inc. Previously Mr. South served as Henry Schein’s Vice President, Corporate Finance from 2008 through April 2022 and Chief Accounting Officer from 2013 through April 2022, responsible for the Company’s internal and external financial reporting and corporate tax functions. Prior to joining the Company in 2008 as Vice President, Corporate Finance, Mr. South held several leadership roles at Bristol-Myers Squibb, where he served as Vice President, Finance, for the Cardiovascular and Metabolic business lines, Vice President, Controller, for its U.S. Pharmaceutical Division, and Vice President, Corporate General Auditor. Prior to Bristol-Myers Squibb, he served as North American Director of Corporate Audit at PepsiCo, and held several roles of increasing responsibility with PricewaterhouseCoopers LLP, where he advised clients located in the United States, Europe and Latin America. Mr. South is a certified public accountant. Mr. South earned bachelor's degrees in accounting and business administration from Illinois State University.
Chief Executive Officer, Global Oral Reconstruction Group
Dr. Willi joined Henry Schein, Inc. in 2013, and is currently Chief Executive Officer, Global Oral Reconstruction Group, which includes the Company's dental implant and bone regeneration products businesses and dental laboratory products and services business. He is a Member of the Company's Executive Management Committee.
Previously, as President of the Henry Schein Global Dental Surgical Group, Dr. Willi led a portfolio of dental surgical businesses, which includes Camlog and BioHorizons as well as ACE Surgical and medentis medical. Prior to joining Henry Schein, Dr. Willi held senior level roles with Institut Straumann AG as Executive Vice President, Surgical Business Unit. Prior to Straumann, he held roles of increasing responsibility in Medtronic's cardiovascular division and with McKinsey & Company as a management consultant.
Dr. Willi earned Master's degrees in Chemical Engineering and Industrial Management, and a PhD in Technical Sciences from the Swiss Federal Institute of Technology (ETH) in Zurich. He is an alumnus of the Medtronic Marketing Leader Program at the Wharton School, University of Pennsylvania.
Co-Chief Executive Officer, Global Oral Reconstruction Group
BIANKA WILSON has been with the Company since 2018, and in her current position as Co-Chief Executive Officer of the Global Oral Reconstruction Group (GORG) since April 2024. She is also a member of our Executive Management Committee. Ms. Wilson is responsible for co-leading GORG’s business globally, with focus on Europe and APAC. Prior to her current role, Ms. Wilson served as the Chief Financial Officer of GORG from 2018 to April 2024. Prior to joining Henry Schein, Ms. Wilson held key roles in finance and consulting. She served as the CFO of a public Swiss medical communication technology company for four years and spent 18 years at KPMG, both in the United States and Switzerland. During her initial five years at KPMG, she worked as an auditor and earned her certification as a US Certified Public Accountant; in her final five years at KPMG, she held the position of Advisory Partner and Global Accounts Lead Partner. Leveraging her extensive financial expertise, Ms. Wilson advised international public companies on various critical matters such as mergers and acquisitions, financial reporting, enterprise resource planning implementations and finance process optimization. Ms. Wilson has an Executive MBA from the University of Edinburgh and the ENPC School of International Management in Paris, a Master's degree in professional accounting from the University of Texas at Austin, and a Bachelor's degree from Cameron University, Lawton, Oklahoma.
R. STEVEN BOGGAN has been with the Company since 2014, and in his current position as Co-Chief Executive Officer of the Global Oral Reconstruction Group (GORG) since April 2024. He is also a member of our Executive Management Committee. Mr. Boggan is responsible for co-leading GORG’s business globally, with focus on the Americas, Middle East, and Africa. Mr. Boggan has served in a variety of leadership roles at the Company since joining as President and CEO of BioHorizons, which the Company acquired in 2014, including Chief Commercial Officer of GORG from 2018 to April 2024. Prior to joining the Company, Mr. Boggan was President and CEO of BioHorizons from 2000 to 2014 after joining in 1995 and employed in the Research and Development and Marketing Departments of Dow Corning Wright and Wright Medical Technology from 1989 to 1995. Mr. Boggan has an M.B.A. from the University of Memphis, an M.S. in Biomedical Engineering from the University of Alabama at Birmingham, and a B.S. in Biological Engineering in Mississippi State University.
Chief Executive Officer, Henry Schein Products Group
TOM POPECK has been with the Company since 2019, and in his current position as Chief Executive Officer of the Henry Schein Products Group since January 2025. He is also a member of our Executive Management Committee. Mr. Popeck leads the Henry Schein Products Group, which includes all entities that design, manufacture, source, sell and market our own branded products, including our Global Oral Reconstruction Group (GORG) and our Healthcare Specialties Group (HSG). Prior to holding his current position, Mr. Popeck served as Chief Executive Officer, and prior to that, President, of our HSG, which included more than 20 business units operating in North America, South America, Europe and Asia. Mr. Popeck has spent over two decades leading businesses in orthopedics and industrial manufacturing, including extensive experience in the medical device sector. Prior to joining the Company, Mr. Popeck held various sales leadership and general management executive positions, including leading Stryker’s Foot & Ankle business unit as Vice President and General Manager during his 11-year tenure with the company. Mr. Popeck earned his Bachelor's in Engineering from Stevens Institute of Technology in Hoboken, NJ.
